Nang Kuang Pharmaceutical Co Ltd
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.… Read more
Market Cap & Net Worth: Nang Kuang Pharmaceutical Co Ltd (1752)
Nang Kuang Pharmaceutical Co Ltd (TW:1752) has a market capitalization of $111.56 Million (NT$3.69 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #21547 globally and #1186 in its home market, demonstrating a -0.81% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nang Kuang Pharmaceutical Co Ltd's stock price NT$36.55 by its total outstanding shares 100988472 (100.99 Million).
Nang Kuang Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Nang Kuang Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $129.53 Million to $111.56 Million (-0.20% CAGR).
Nang Kuang Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nang Kuang Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Nang Kuang Pharmaceutical Co Ltd's market cap is 0.05 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.47x
Nang Kuang Pharmaceutical Co Ltd's market cap is 0.47 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $112.68 Million | $1.55 Billion | $225.50 Million | 0.07x | 0.50x |
| 2017 | $99.61 Million | $1.50 Billion | $185.82 Million | 0.07x | 0.54x |
| 2018 | $83.16 Million | $1.54 Billion | $101.23 Million | 0.05x | 0.82x |
| 2019 | $113.09 Million | $1.76 Billion | $217.44 Million | 0.06x | 0.52x |
| 2020 | $106.75 Million | $1.75 Billion | $183.40 Million | 0.06x | 0.58x |
| 2021 | $103.79 Million | $1.78 Billion | $196.11 Million | 0.06x | 0.53x |
| 2022 | $181.05 Million | $1.94 Billion | $352.00 Million | 0.09x | 0.51x |
| 2023 | $156.64 Million | $2.15 Billion | $198.41 Million | 0.07x | 0.79x |
| 2024 | $125.60 Million | $2.20 Billion | $243.41 Million | 0.06x | 0.52x |
| 2025 | $113.85 Million | $2.16 Billion | $243.95 Million | 0.05x | 0.47x |
Competitor Companies of 1752 by Market Capitalization
Companies near Nang Kuang Pharmaceutical Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Nang Kuang Pharmaceutical Co Ltd by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Nang Kuang Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Nang Kuang Pharmaceutical Co Ltd's market cap moved from $129.53 Million to $ 111.56 Million, with a yearly change of -0.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$111.56 Million | -2.01% |
| 2025 | NT$113.85 Million | -9.36% |
| 2024 | NT$125.60 Million | -19.81% |
| 2023 | NT$156.64 Million | -13.48% |
| 2022 | NT$181.05 Million | +74.45% |
| 2021 | NT$103.79 Million | -2.78% |
| 2020 | NT$106.75 Million | -5.60% |
| 2019 | NT$113.09 Million | +35.98% |
| 2018 | NT$83.16 Million | -16.51% |
| 2017 | NT$99.61 Million | -11.60% |
| 2016 | NT$112.68 Million | -13.01% |
| 2015 | NT$129.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nang Kuang Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $111.56 Million USD |
| MoneyControl | $111.56 Million USD |
| MarketWatch | $111.56 Million USD |
| marketcap.company | $111.56 Million USD |
| Reuters | $111.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.